These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32695243)
41. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. Wang L; Huang J; Jiang M; Sun L J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234 [TBL] [Abstract][Full Text] [Related]
42. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma]. Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257 [TBL] [Abstract][Full Text] [Related]
43. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. Buta C; Benabou E; Lequoy M; Régnault H; Wendum D; Meratbene F; Chettouh H; Aoudjehane L; Conti F; Chrétien Y; Scatton O; Rosmorduc O; Praz F; Fartoux L; Desbois-Mouthon C J Exp Clin Cancer Res; 2016 Aug; 35(1):126. PubMed ID: 27514687 [TBL] [Abstract][Full Text] [Related]
44. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670 [TBL] [Abstract][Full Text] [Related]
45. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905 [TBL] [Abstract][Full Text] [Related]
46. [Expression and significance of NET-1 protein in hepatocellular carcinoma]. Chen L; Li XY; Wang Y; Zhu YY; Zhu JW Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):917-21. PubMed ID: 18478931 [TBL] [Abstract][Full Text] [Related]
47. Correlation of HBV and HCV with CH, LC, HCC in liver biopsied tissue at Rajavithi Hospital. Komindr A; Praditphol N; Suphanpayak S; Sae-Eaw R; Nussati A; Tujinda S; Kongteeraphap P; Intaraksa S; Rukchampong R; Deesawat T J Med Assoc Thai; 2005 Jun; 88(6):788-809. PubMed ID: 16083220 [TBL] [Abstract][Full Text] [Related]
48. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma. Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T Platelets; 2015; 26(6):577-82. PubMed ID: 25275728 [TBL] [Abstract][Full Text] [Related]
49. Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Ichiba M; Maeta Y; Mukoyama T; Saeki T; Yasui S; Kanbe T; Okano J; Tanabe Y; Hirooka Y; Yamada S; Kurimasa A; Murawaki Y; Shiota G Liver Int; 2003 Oct; 23(5):338-45. PubMed ID: 14708894 [TBL] [Abstract][Full Text] [Related]
50. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
51. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma. Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973 [TBL] [Abstract][Full Text] [Related]
52. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation. Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348 [TBL] [Abstract][Full Text] [Related]
53. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605 [TBL] [Abstract][Full Text] [Related]
54. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
55. Cytokeratin 8 and 18 expression in imprint smears of chronic viral hepatitis, autoimmune hepatitis and hepatocellular carcinoma. A preliminary study. Athanassiadou P; Psyhoyiou H; Grapsa D; Gonidi M; Ketikoglou I; Patsouris E Acta Cytol; 2007; 51(1):61-5. PubMed ID: 17328497 [TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical Expression of Insulin-Like Growth Factor-1 Receptor and Its Association with Clinicopathological Parameters in Hepatocellular Carcinoma. Peloso Maia ML; Albuquerque RM; do Carmo Silva SD; Lima CX; Costa Diniz PH; Vieira Teixeira Vidigal P Oncology; 2024; 102(6):494-502. PubMed ID: 37989120 [TBL] [Abstract][Full Text] [Related]
58. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [TBL] [Abstract][Full Text] [Related]
59. Selenoprotein P mRNA expression in human hepatic tissues. Li CL; Nan KJ; Tian T; Sui CG; Liu YF World J Gastroenterol; 2007 Apr; 13(16):2363-8. PubMed ID: 17511039 [TBL] [Abstract][Full Text] [Related]
60. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma]. Chen Y; Tang ZY; Li J Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]